Three founder mutations in BRCA1 and BRCA2 contribute to the risk of hereditary breast and ovarian cancer in Ashkenazi Jews (AJ). They are observed at increased frequency in the AJ compared to other BRCA mutations in Caucasian non-Jews (CNJ). Several authors have proposed that elevated allele frequencies in the surrounding genomic regions reflect adaptive or balancing selection. Such proposals predict long-range linkage disequilibrium (LD) resulting from a selective sweep, although genetic drift in a founder population may also act to create long-distance LD. To date, few studies have used the tools of statistical genomics to examine the likelihood of long-range LD at a deleterious locus in a population that faced a genetic bottleneck. We s...
In the Ashkenazim, three recurrent germline mutations have been identified in the breast carcinoma s...
BackgroundGenetic isolates such as the Ashkenazi Jews (AJ) potentially offer advantages in mapping n...
The ability to establish genetic risk models is critical for early identification and optimal treat...
Three founder mutations in BRCA1 and BRCA2 contribute to the risk of hereditary breast and ovarian c...
International audienceThree founder mutations in BRCA1 and BRCA2 contribute to the risk of hereditar...
BackgroundWe studied linkage disequilibrium (LD) patterns at the BRCA1 locus, a susceptibility gene ...
In Ashkenazi Jewish (AJ) high risk families 3 mutations [2 in BRCA1 (c. 68_69del and c.5266dup) and ...
Certain mutations in BRCA1 and BRCA2 genes are frequent in the Ashkenazi Jewish population. Several ...
In Ashkenazi (East European) Jews, three predominant mutations in BRCA1 (185delAG and 5382insC) and ...
SummaryBased on breast cancer families with multiple and/or early-onset cases, estimates of the life...
Ovarian cancer is a component of the autosomal-dominant hereditary breast-ovarian cancer syndrome an...
In the Ashkenazim, three recurrent germline mutations have been identified in the breast carcinoma s...
BackgroundGenetic isolates such as the Ashkenazi Jews (AJ) potentially offer advantages in mapping n...
The ability to establish genetic risk models is critical for early identification and optimal treat...
Three founder mutations in BRCA1 and BRCA2 contribute to the risk of hereditary breast and ovarian c...
International audienceThree founder mutations in BRCA1 and BRCA2 contribute to the risk of hereditar...
BackgroundWe studied linkage disequilibrium (LD) patterns at the BRCA1 locus, a susceptibility gene ...
In Ashkenazi Jewish (AJ) high risk families 3 mutations [2 in BRCA1 (c. 68_69del and c.5266dup) and ...
Certain mutations in BRCA1 and BRCA2 genes are frequent in the Ashkenazi Jewish population. Several ...
In Ashkenazi (East European) Jews, three predominant mutations in BRCA1 (185delAG and 5382insC) and ...
SummaryBased on breast cancer families with multiple and/or early-onset cases, estimates of the life...
Ovarian cancer is a component of the autosomal-dominant hereditary breast-ovarian cancer syndrome an...
In the Ashkenazim, three recurrent germline mutations have been identified in the breast carcinoma s...
BackgroundGenetic isolates such as the Ashkenazi Jews (AJ) potentially offer advantages in mapping n...
The ability to establish genetic risk models is critical for early identification and optimal treat...